BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02506153-completion@plaintrial.com
DTSTAMP:20261027T220110Z
DTSTART;VALUE=DATE:20270123
SUMMARY:Physician/Patient Choice of Either High-Dose Recombinant Interferon
  Alfa-2B or Ipilimumab\, Versus Pembrolizumab in Treating Patients With St
 age III-IV High Risk Melanoma That Has Been Removed by Surgery — estimat
 ed completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT02506153
URL:https://plaintrial.com/trial/NCT02506153
END:VEVENT
END:VCALENDAR